Authors
Latest:
A Case of Cerebral Amyloid Angiopathy-Related Inflammation With Pathologic FeaturesA 71-year-old woman presented to the emergency department with subacute headaches and altered behavior that was initially attributed to emotional distress. What did the tests show?
Latest:
The Next Wave of Stroke Care Beyond the Acute Phase: Matthew Schrag, MD, PhDThe associate professor of neurology at Vanderbilt University Medical Center discussed exploring promising opportunities in other phases outside of the acute phase of ischemic stroke. [WATCH TIME: 3 minutes]
Latest:
A Clinical Update of Intracerebral HemorrhageA summary of current treatment guidelines, application, and emerging developments in the area of spontaneous nontraumatic ICH.
Latest:
A Clinical Update of Intracerebral HemorrhageA summary of current treatment guidelines, application, and emerging developments in the area of spontaneous nontraumatic ICH.
Latest:
A Case of PML-IRIS: Diagnostic and Treatment ConsiderationsOn the challenges of treating progressive multifocal leukoencephalopathy in MS patients.
Latest:
A Case of PML-IRIS: Diagnostic and Treatment ConsiderationsOn the challenges of treating progressive multifocal leukoencephalopathy in MS patients.
Latest:
Diagnosing and Treating MELAS: Issues for CliniciansDifferential diagnosis and treatment of mitochondrial encephalomyopathy lactic acidosis and stroke-like syndrome.
Latest:
Diagnosing and Treating MELAS: Issues for CliniciansDifferential diagnosis and treatment of mitochondrial encephalomyopathy lactic acidosis and stroke-like syndrome.
Latest:
Saliva: A New Tool for Concussion Diagnosis?Recognizing the need for objective markers of brain injury, researchers have dedicated extensive efforts to developing concussion biomarkers.
Latest:
The Role of Monoclonal Antibodies and Emerging Combination Treatments to Expand Alzheimer Therapeutics: Howard Fillit, MDThe cofounder and chief science officer of the Alzheimer's Drug Discovery Foundation talked about how Alzheimer disease treatment may evolve through combination therapies, adding potential anti-tau and anti-inflammatory agents to improve patient outcomes. [WATCH TIME: 5 minutes]
Latest:
Diagnosis of Progressive Supranuclear PalsyProgressive supranuclear palsy (PSP), initially called Steele-Richardson-Olszewski syndrome, is a sporadic neurodegenerative disease.
Latest:
Diagnosis of Progressive Supranuclear PalsyProgressive supranuclear palsy (PSP), initially called Steele-Richardson-Olszewski syndrome, is a sporadic neurodegenerative disease.
Latest:
Diagnosis of Progressive Supranuclear PalsyProgressive supranuclear palsy (PSP), initially called Steele-Richardson-Olszewski syndrome, is a sporadic neurodegenerative disease.
Latest:
Diagnosis of Progressive Supranuclear PalsyProgressive supranuclear palsy (PSP), initially called Steele-Richardson-Olszewski syndrome, is a sporadic neurodegenerative disease.
Latest:
Caring for Patients With ALS: A Brief ReviewAlthough there is no cure for ALS, there are treatments available that can improve the quality of life and prolong survival.
Latest:
Experience with Risdiplam and Unmet Needs in SMAJames Wymer, MD discusses his firsthand experience with risdiplam and identifies a key unmet need in the treatment of spinal muscular atrophy.
Latest:
Epilepsy Treatments QuizHow well versed are you in various epilepsy treatments? Our quiz covers medications and non-drug treatments.
Latest:
A Study of Thousands: Adolescent Cognition and Alzheimer DiseasePotential risk factors may identify those at risk for AD and similar disorders as early as adolescence.
Latest:
Top Five Issues in Sports NeurologyWith a plethora of issues currently being debated in the field of sports neurology, Dr Seifert explores the top 5.
Latest:
Neuro-Ophthalmologic Disorders: Issues in Diagnosis and TreatmentNeurologists may be the first or only clinicians to recognize the 5 potentially dangerous neuro-ophthalmologic conditions described in this article.
Latest:
Neuro-Ophthalmologic Disorders: Issues in Diagnosis and TreatmentNeurologists may be the first or only clinicians to recognize the 5 potentially dangerous neuro-ophthalmologic conditions described in this article.
Latest:
Neuro-Ophthalmologic Disorders: Issues in Diagnosis and TreatmentNeurologists may be the first or only clinicians to recognize the 5 potentially dangerous neuro-ophthalmologic conditions described in this article.
Latest:
In Vivo Biomarkers for Chronic Traumatic EncephalopathyChronic traumatic encephalopathy is a neurodegenerative disease that is believed to be a consequence of exposure to repetitive head impacts, including concussions and subconcussive injuries.
Latest:
In Vivo Biomarkers for Chronic Traumatic EncephalopathyChronic traumatic encephalopathy is a neurodegenerative disease that is believed to be a consequence of exposure to repetitive head impacts, including concussions and subconcussive injuries.
Latest:
The Role of Diet in Brain HealthMore and more, modern medicine is recognizing the influence of diet on good health. Now, research shows that eating a diet rich in vegetables, fruits, nuts, and fish may result in larger total brain volumes and thereby better long-term brain health.
Latest:
Effects of Bioavailable Curcumin on Age-Related Cognitive SymptomsA limitation of many supplements is that they are poorly absorbed into the bloodstream after ingestion. A new study used a form of curcumin that had high bioavailability to test its effectiveness in protecting cognition.
Latest:
Neurological Manifestations of HIVNeurologic complications remain a significant cause of long-term disability. Understanding and recognizing these conditions is crucial in effectively managing HIV.
Latest:
Neurological Manifestations of HIVNeurologic complications remain a significant cause of long-term disability. Understanding and recognizing these conditions is crucial in effectively managing HIV.
Latest:
Driving and Epilepsy: Issues to Discuss With Your PatientsBecause automobiles are such an important aspect of our culture, driving restriction is an enormous problem for many of the 65 million individuals with epilepsy worldwide and their families.
